FDA Inspection 1258872 — Neetu Talreja, M.D.
The FDA completed an inspection of Neetu Talreja, M.D. on December 20, 2024 in Boise, ID. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- December 20, 2024
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Boise, ID (United States)
Additional Details
Clinical BA/BE